Oto-acoustic emissions (OAEs) are an audiometric diagnostic test that allows quick objective measure of hair cell function in the inner ear. It is a reflection of hearing function at the interface of conductive and sensorineural components in the human ear. Unfortunately, it is not commonly used due to the unique expertise and niche equipment required to successfully carry it out. This article is to further shed light about the use of such tests to junior doctors so that such resources can be better utilised. It also reviews the current and possible future applications of OAEs at the frontiers in otology today.
INTRODUCTION
The Singapore General Hospital ENT hearing centre has an armamentarium of audiological resources to help establish hearing thresholds accurately and to determine the presence of impairment; site, type (conductive, sensorineural or mixed) and severity of the hearing loss. Tests are mainly divided into behavioural (pure tone and speech) and objective (tympanometry, auditory evoked potentials, otoacoustic emissions etc.) By and far, the workhorse audiological investigations of choice are mainly behavioural pure tone and speech audiometry testing which requires the cooperation of the patient. However, objective tests such as the acoustic reflexes and oto-acoustic emissions (OAEs) are not commonly used due to the unique expertise and niche equipment required to successfully carry it out.
Oto-acoustic emission measurements are a standard part of the audiological diagnostic test battery. It is a means of non-invasively acquiring information about disorders of an essential element of sound processing and hence allows assessment of loss of sensitivity, compression, and frequencyselectivity of the hearing organ. They are a fast and easy-to-handle method for objectively examining cochlear function.
Present OAEs in an ear indicate many things about the auditory system. First, they tell us that the conductive mechanism of the ear is functioning properly. This includes proper forward and reverse transmission, no blockage of the external auditory canal, normal tympanic membrane movement, and a functioning impedance matching system. Present OAEs also indicate that outer hair cell (OHC) function is normal, which, in most cases, correlates with normal hearing sensitivity. Subjective tests such as pure tone audiometry, are only able to assess disorders of sound processing as a whole. Tympanometry, OAEs, and auditory brainstem responses (ABRs), in combination, allow
Proceedings of Singapore Healthcare  Volume 24  Number 2  2015 provide a means of conveying vibrational energy back to the middle ear in a reversal of the process that normally delivers auditory stimulation to the hair cells. Theses sounds can be picked up and recorded by a sensitive microphone fitted in the ear canal. Most patients with cochlear sensorineural hearing impairment have a loss of this amplification mechanism.
Oto-acoustic emissions are generated only when the organ of corti and the middle ear are in near normal conditions; Being able to reach as loud as 30dB SPL. They measure specifically cochlear hair function in the peripheral auditory system.
HISTORY OF OAEs
Oto-acoustic emissions were discovered in July 1977 by Professor David Kemp, a physicist working at the Royal National Ear, Nose and Throat Hospital at that time 1 . Kemp was conducting psychoacoustic experiments on his own ears measuring changes in hearing thresholds and loudness perception associated with small changes in frequency. He was motivated by his observations that hearing thresholds exhibited periodic patterns of peaks and valleys, as did loudness estimates, when measured in small increments of frequency. Interestingly, the valleys in hearing thresholds (frequencies where hearing appeared to be most sensitive) approximately aligned with peaks in loudness estimates (frequencies where sounds seemed disproportionately louder). These observations reminded Kemp of a prediction made by the British astrophysicist Thomas Gold. Upon observing the expansive dynamic range of hearing, Gold had postulated that the ear must contain a nonlinear amplifier -an amplifier that provided gain for low inputs to make them audible but became passive to make high inputs tolerable. This is known today as the cochlea amplifier; Kemp connected his observation of the peaks and valleys in behavioural data and Gold's predictions and hypothesised that the valleys in hearing sensitivity and peaks in loudness estimates could be due to these sounds produced by the ear. That is, the presence of an internal sound source at a given frequency would add to any external tone played leading to hypersensitivity in threshold measures as well as a heightened perception of loudness. With this notion, he salvaged a miniature microphone from a hearing aid and sealed it with silicone putty to keep the sound in over his ear, and attached the output to an analyser to see if sounds could be picked up.
for a differentiation between sound-conductive, cochlear, and neural hearing loss. Minute changes in hearing capability are detectable by OAEs. They are therefore a suitable means for detecting early impairment, for example, caused by noise exposure or ototoxic drugs, as well as for monitoring hearing recovery after a sudden hearing loss. They are also the first choice investigations for newborn hearing screening programs around the world. They are easy to obtain, non-invasive, and provide reliable information regarding cochlear status in a relatively short time. With all its benefits, OAE testing does have some limitations; It does not evaluate the inner hair cells (IHC), 8th cranial nerve function, ascending central auditory pathway, or auditory processing function. Thus, they are not always used in isolation.
THE SCIENCE BEHIND OAEs
Oto-acoustic emissions are air pressure fluctuations in the ear canal caused by vibration of the eardrum driven by the cochlea. It is a common misconception to think of OAE as sounds "emitted" by the cochlea itself, but technically sound pressure is not produced in any measurable quantity until the eardrum, driven by the cochlea, vibrates against the adjacent air in the ear canal. The physical construction of the middle ear positively helps us to observe OAEs. The efficient coupling that the middle ear provides between the low impedance of the thin light eardrum and the high impedance of the closed fluid-filled capsule, that is the inner ear, operates equally well in both directions. It matches cochlea to eardrum just as well as eardrum to cochlea.
How does the cochlea vibrate the eardrum to create sound, i.e., an OAE? Simply put, moving the eardrum from within the sealed fluid-filled cochlea requires an imbalance of vibrational fluid pressure on the oval and round windows. This requires the diversion of vibrational energy away from the primary hearing process and the transmission of that energy back to the base of the cochlea in a way that can physically create this pressure difference and cause middle ear motion. The initial source of vibrational energy needed to generate OAEs is generally considered to be the electromotility of the three outer rows of the cochlea's sensory hair cells, the outer hair cells (OHCs) 1, 2 . Motility of OHCs as they respond to auditory stimulation provides the engine of the "cochlear amplifier." A reverse travelling wave along the basilar membrane would Indeed they did and today we know them as otoacoustic emissions (OAEs) and use them routinely for a multitude of clinical purposes.
METHOD
Oto-acoustic emissions are measured by presenting a series of sounds or "clicks" to the ear through a probe that is snugly inserted into the ear canal probe (Fig. 1 ). It contains:
1. A loudspeaker that generates the sounds 2. A sensitive microphone that measures the resulting OAEs that are produced in the cochlea and are transmitted through the middle ear into the outer ear canal 3. A signal separating processor that can discriminate the sound of the OAE from the stimulus sound and other noise.
A probe with a soft flexible tip is inserted in the ear canal to obtain a seal. Different probes are used for neonates and adults and are calibrated differently because of the significant difference in ear canal volume.
Oto-acoustic emissions are appropriate for use in difficult to test patients: newborn infants, young uncooperative children and individuals with developmental delays. Because no behavioural response is required, OAEs can be obtained even from patients who are comatose. The recording time for OAEs is quick. Quiet and cooperative patients usually require less than a few minutes per ear to get an accurate reading but for uncooperative or noisy patients, recordings may take significantly longer or may be impossible to obtain on a given visit. Each individual has his/ her own characteristic repeatable OAEs and hence repeatability or reproducibility of OAEs can help to verify the response.
Although testing does not require patient cooperation, a seal probe, which helps to block out external noise, ear canal patency with an unobstructed outer ear canal and absence of significant middle ear pathology and background room noise should be below 40dB due to the sensitivity of OAEs to noise. All OAEs are analysed relative to the noise floor; therefore, reduction of physiologic and acoustic ambient noise is critical for good recordings. Depending on the intended portion of the cochlea that is of concern (frequency specific response), the acoustic stimulus can be varied from no stimulus, to click stimuli (wide-band noise), or tones (narrow band noise). 
TYPES OF OAEs
Oto-acoustic emissions can be broadly classified into two groups (Table 1) . Two main types of evoked OAE are used in clinical practice: TEOAEs & DPOAEs.
Both are complementary, as the former is best detecting threshold elevation below 4kHz, giving an overview of cochlear activity; the latter above it, giving specific quantitative information about sound processing at distinct cochlear places. In short, the TEOAE response "sees" almost the whole cochlea, whereas the DPOAE response reflects only a limited region of the cochlea but gives some indication of the extent of loss.
The advantages of DPOAE as compared to TEOAE are summarised as below:
• First, DPOAEs are able to test higher frequencies than TEOAEs, making them more sensitive to the high frequencies affected first in certain conditions e.g. ototoxicity and noise induced damage.
• Secondly, DPOAEs can be recorded in the presence of mild to moderate hearing loss as compared to TEOAEs, which give a more binary response. Therefore, if hearing loss already exists, that patient can still be monitored (so long as their hearing loss is not too great) for possible progression. Lastly, using DPOAEs can provide some indication of degree and configuration of the hearing loss given its ability to estimate (albeit not accurately) thresholds as well as its spectrum of frequency detection.
CLINICAL APPLICATIONS
There are four main OAE applications in clinical diagnostics: newborn hearing screening, Topological diagnostics, quantitative evaluation of hearing loss and recruitment, and monitoring cochlear function.
Newborn Hearing Screening
Otoacoustic emissions (TEOAE and DPOAE) are widely regarded as being suitable for screening in newborns and infants [3] [4] [5] , since they are not present in the case of OHC dysfunction 6, 7 . The premise for this approach is that inner-ear hearing loss always includes OHC damage or malfunction. Its use is widely incorporated into universal newborn hearing screening programs and in pediatric clinics where the patients are too young to be cooperative in conventional hearing tests 8 . The OAE technology can have a sensitivity of 95% and specificity of 90% whilst the referral rate is 5-20% when screening is performed within the first 24 hours of life 10 .
This is usually combined with ABR methods for screening protocols due to the disadvantage of OAEs giving false positive results ranging from 11 to 35% 7, 11 in paediatric patients with significant conductive losses 12 ; more often than not due to Eustachian tube dysfunction or residual amniotic fluid in the tympanic cavity which attenuates the OAE signal. To avoid high referral rates, some hearing screening protocols add on ABR screening before referral for diagnostic assessment 13 .
It is widely accepted that children with untreated loss generally perform poorly academically as compared to their peers. Hearing loss affects both reading and writing skills, resulting in poor communication and language skills. The literature supports the trend that the longer the delay in intervention, the poorer the academic outcomes tended to be 14 . In Yoshinaga-Itano's 10-year longitudinal study 15 on the effect of early identification on the development of deaf and hard-of-hearing infants and toddlers, the language abilities of hearing-impaired children identified before 6 months were pitted against those identified after 6 months. The results were not surprising, whereby those detected early before 6 months had a significantly better average language quotient as compared to those after 6 months, across all degrees of hearing loss. In addition, if such a disability is untreated, it can also lead to emotional and psychosocial handicaps 16 . Delayed identification and management can impede a child's ability to adapt to the hearing world, and if remedied early facilitates full advantage of the plasticity of the developing sensory systems, so as to allow normal social development and improved future prospects.
In Singapore, the Universal National Hearing Screening programme was set up in 2002, and first implemented in KK Women's and Children's Hospital (KKWCH) which accounts for a third of deliveries; and subsequently adopted by all public and private hospitals in the country which boasts obstetrics services. The programme 17 aims to screen all neonates before they are discharged from the hospital. Newborns who failed the screening had a repeat screening within 4 to 6 weeks; failing both screening tests would result in referral for audiological diagnosis and medical evaluation before the age of 3 months. With successful implementation of an extensive UNHS coupled with early and effective intervention, this maximises the chances of affected children to better integrate into mainstream society.
Topological Diagnostics
The management for a hearing disorder can be developed only after knowing which stage of the auditory pathway is impaired. Psychoacoustic tests are able to differentiate between conductive, sensorineural or mixed hearing loss by evaluating the difference between air and bone-conductive pure-tone thresholds. However, the differentiation between a sensory (cochlear) and a neural disorder with subjective testing is unreliable. In addition, in uncooperative patients or infants, psychoacoustic tests cannot be performed. In such cases, only objective tests help in achieving the goal of determining end-organ integrity.
The use of OAEs to assist in the diagnosis of retrocochlear pathologies have become standard in clinical practice. OAEs arise from the peripheral auditory system; therefore, a logical conclusion is that they will be present in cases of retro-cochlear pathology. One of the most common applications would be in the diagnosis of auditory neuropathy; In such a condition, the patient displays auditory characteristics consistent with normal OHC and abnormal neural function at the level of the VIII th nerve; where these characteristics are observed on clinical audiologic tests as normal oto-acoustic emissions (OAEs) in an absent or severely abnormal auditory brainstem response (ABR), result in poor word recognition and variable audiogram findings 18, 19 . These patients are distinguished from patients with space-occupying lesions, such as VIII th nerve tumours, or multiple sclerosis, in that radiological evaluation yields normal results and even the most peripheral responses from the VIII th nerve are absent. The role of OAEs is evident in ruling out OHC dysfunction, and together with a normal tympanometry points to a retrocochlear lesion.
A combination of present OAEs with altered ABRs must also bring into mind other differential diagnosis. These cases belong to clinical profiles involving vestibular schwanommas and other central auditory system disorders. In the setting of a tumour in the internal auditory canal, interestingly OAEs (TEOAES or DPOAEs) can be affected or Proceedings of Singapore Healthcare  Volume 24  Number 2  2015 unaffected by the presence of space occupying lesion such as a vestibular schwanomma. An explanation for such data can be derived from information of how the growth of the tumor affects the vascular supply of the cochlea; especially if it impinges on the internal auditory artery or how the growth of the tumors induces mechanical pressure alterations on the vascular supply and the cochlea itself 20 . OAE-based measures can provide information on the sensory component of any hearing disorder, thus they can provide precise indices of evaluating sensori-neural hearing impairment cases. In addition, in patients with suspected labrynthine schwanommas, the OAE can be of some assistance in the differentiation of cochlea and vestibular types of schwannomas serving as an adjunct to imaging investigations 21 .
Quantitative Evaluation of Hearing Response and Recruitment
The concept behind this lies in the ability of OAEs to identify regions of the cochlea with damage, which can assist in programming a hearing aid. Simply explained, when OAEs are absent, we assume hearing loss of greater than about 25 dB HL at the frequency where the emission is absent and this gives us some idea of hearing levels. Bear in mind however, amplification protocols for different patient groups are much more complex, usually requiring a battery of tools such as ABR before we can use this data to program amplification for these patients. Oto-acoustic emissions are one of the many tools that help influence the programming.
Monitoring Cochlea Function
Oto-acoustic-emission measures are stable through time in any particular individual and hence are capable of monitoring recovery from OHC impairment 22, 23 . Three main approaches have been used for monitoring the effects of ototoxic medications: basic audiologic assessment, high frequency audiometry (HFA; 10-18 kHz), and OAEs 24 . Ototoxic drugs exert their effect on OHC function (although not solely on OHCs), and OAEs are OHC dependent. With ototoxicity, OAEs have been shown to decrease simultaneously with changes in HFA thresholds and before changes appear in the conventional audiometric frequencies 24 . Part of this group are therapeutic drugs such as antibiotic (e.g., aminoglycosides) and antitumor chemotherapeutic (e.g., cisplatin) agents 25 , are reported to induce an irreversible hearing loss, which typically affects the highest frequencies first, with hearing loss systematically progressing to the lower frequencies 26, 27 .
The biggest limitation to OAEs is that they are very sensitive to middle ear dysfunction, which is common in children and in those who are immunocompromised. Although OAEs are being employed for ototoxicity monitoring, they are rarely used in isolation. A change in OAEs from one test session to the next is a strong indicator for the need for more conventional and HFA testing. This allows cost effective testing whereby further testing is avoided unless OAEs suggest otherwise. Early detection of ototoxicity is an important signal for alternate management options such as substitution of medications, change of dosages, and mode of administration.
Much like the use of OAEs in ototoxicity monitoring, OAEs can be used to provide objective confirmation of cochlea dysfunction in patients with normal audiograms. In noise induced hearing loss, threshold elevations are proven to be in the mid to high frequencies 28 ; OAE protocols can thus be used very efficiently to monitor small elevations in threshold progress 29 . Oto-acoustic emissions can provide an early and reliable warning sign of cochlea dysfunction due to noise/music exposure before any problem is evident on the audiogram 30 . Some studies even go as far as to say that OAEs can be a diagnostic predictor for noise-inducedhearing-loss-risk 31 .
Intra-operatively, its use can be seen in its live monitoring of changes in cochlea status over time during surgery, where morbidity is high and utmost care is taken to minimise damage to cochlea nerve function 32 . For example in the context of vestibular schwanomma surgery, OAEs are taken during pre-as well as intraoperative monitoring to prognosticate post-operative cochlea function 33, 34 .
Future Applications
Our persistent uncertainties about OAEs are a testament to their complex nature. Not only are we still debating about their generation mechanisms, different ideas about how they transmit out of the cochlea still exist. One thing is clear, the uses of OAE measurements as diagnostic tools have obvious advantages (especially in their objectivity and restriction to the cochlea) that they have been rapidly incorporated as clinical tools.
The holy grail is to be able to use OAEs to definitively determine hearing thresholds; currently it cannot be used in isolation for such a purpose. In many cases, it is probably better off to stick with behavioural threshold estimation, but one can certainly see the benefit of having an objective non-invasive tool for gathering threshold information in certain populations and situations. So far, attempts to predict hearing thresholds from DPOAE and TEOAE levels measured in response to fixed-level stimuli varied in frequency were not conclusive 35, 36 . However, there have been efforts at predicting hearing thresholds using DPOAE input/ output functions 37 which may open the door to such an avenue in future.
Age related hearing loss is one of the most ubiquitous pathology that is commonly seen in clinics. It is well known that signs of aging are evident at higher frequencies. However, new findings have demonstrated that signs of aging are visible in DPOAE levels at frequencies as low as 1000 Hz for individuals as young as 20 years old 38 . This forces us to change our perception about auditory aging and when might be the right time to start awareness campaigns to protect our ears.
With innovative applications of OAEs emerging everyday, there is no lack of controversy over its reliability in uses such as for tinnitus monitoring, Meniere's disease and even acoustic fingerprinting. Further research has to be put into its validation for such purposes. No doubt, OAEs have been able to effectively segregate good and bad ears over the past decade, with newborn hearing screening as the main driving force. The techniques for making such decisions are still being refined today 39 .
Its main strength is in its non-invasive, frequency specific, objective measurement of cochlea audiological function, which charges it with invaluable roles. It is safe to say that OAEs will continue to play an important role in routine audiological assessments as well as its less known uses. Its promise in further developments can only open up exciting possibilities in the years to come.
